Functional Neuromodulation has received approval from the FDA to conduct a study on the use of deep brain stimulation for patients with mild Alzheimer's Disease. The study plan is currently under review at Johns Hopkins Medical Center. Once the study plan is approved and the researchers are prepared, then patients will begin to be screened to see if they are eligible for this clinical study.

If you are interested in having someone call you about the study in the future, please e-mail your name and phone number to jpedroso@jhmi.edu.